Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.3660
+0.0412
+(12.68%)
At close: 3:29:01 PM GMT+1
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jeppe Krog Rasmussen | Founder, Member of Executive Board, Director & CEO | -- | -- | 1995 |
| Mr. Peter Hauberg Sondergaard | Chief Financial Officer | -- | -- | 1972 |
| Mr. Jens Markussen | Head of Production | -- | -- | -- |
| Mr. John Morell Frellsen | Chief Commercial Officer | -- | -- | -- |
| Ms. Charlotte Hagedorn Jorgensen | Head of Quality Assurance | -- | -- | -- |
DanCann Pharma A/S
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
DanCann Pharma A/S, a biopharmaceutical company, focuses on discovering, developing, manufacturing, and commercializing therapeutic cannabinoids in various disease areas. It sources, develops, and distributes prescription and over-the-counter cannabinoid-based pharmaceuticals primarily focused on pain patients. The company's development pipeline includes EXT02 CannGros, EXT03 CannGros, EXT04 CannGros, FLS04 CannGros, and FLS05 CannGros. It is also involved in the import and distribution of Bedrocan CannGros, Bedica CannGros, and Bediol CannGros. The company was incorporated in 2018 and is based in Ansager, Denmark.
Corporate Governance
DanCann Pharma A/S’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 17, 2025 at 10:59 AM UTC
DanCann Pharma A/S Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
EVT.BE Evotec SE
8.27
-0.66%
EVT.VI Evotec SE
8.23
-3.58%
TKD.SG Takeda Pharmaceutical Co Ltd
27.50
+1.55%
N4P.L N4 Pharma Plc
0.5250
0.00%
TKUN.TA Tikun Olam-Cannbit Pharmaceuticals Ltd
35.30
-6.12%
PLCN.CN Cannibble Food-Tech Ltd.
0.0200
0.00%
SBX.DE SynBiotic SE
3.6500
+1.11%
INCR.TA InterCure Ltd.
560.00
-1.69%
DICOT.ST Dicot Pharma AB
0.2745
-4.85%
MYCO.CN Mydecine Innovations Group Inc.
0.0050
0.00%